Teva Asks FTC To Tweak Watson-Actavis Merger Fix
The Federal Trade Commission said Tuesday that Teva Pharmaceutical Industries Ltd. has asked to extend a supply agreement it has with Pfizer Inc. for the abuse-resistant opioid painkiller Embeda, requiring changes...To view the full article, register now.
Already a subscriber? Click here to view full article